AAUM (Average Assets Under Management) of ₹328.62 Cr for Apr-Jun 2026 is the combined figure across Direct and Regular plans — sourced from AMFI India's quarterly disclosure. Equity Holdings above shows only the stock portion from the latest portfolio filing.
| Sector | Prev | Curr ▼ | Delta |
|---|---|---|---|
| Pharmaceuticals & Biotechnology | 66.3% | 69.2% | ▲ +2.9% |
| Healthcare Services | 19.3% | 18.4% | ▼ -0.9% |
| Food Products | 2.8% | 2.7% | ▼ -0.2% |
| Industrial Products | 2.0% | 2.0% | ● 0.0% |
| Chemicals & Petrochemicals | 2.2% | 2.0% | ▼ -0.2% |
| Insurance | 1.0% | 1.0% | ● -0.1% |
| Financial Technology (Fintech) | 1.0% | 0.8% | ▼ -0.2% |
| Fertilizers & Agrochemicals | 0.0% | 0.3% | ▲ +0.3% |
| Aerospace & Defense | 0.3% | 0.2% | ● -0.1% |
| Retailing | 1.2% | 0.0% | ▼ -1.2% |
| Sector | Prev | Curr ▼ | Delta |
|---|---|---|---|
| Pharmaceuticals & Biotechnology | 69.2% | 71.3% | ▲ +2.1% |
| Healthcare Services | 18.4% | 17.0% | ▼ -1.4% |
| Food Products | 2.7% | 2.3% | ▼ -0.4% |
| Industrial Products | 2.0% | 2.0% | ● 0.0% |
| Chemicals & Petrochemicals | 2.0% | 1.2% | ▼ -0.8% |
| Financial Technology (Fintech) | 0.8% | 0.9% | ● +0.1% |
| Insurance | 1.0% | 0.8% | ▼ -0.1% |
| Aerospace & Defense | 0.2% | 0.3% | ● +0.0% |
| Fertilizers & Agrochemicals | 0.3% | 0.3% | ● 0.0% |
Comparing Jul 2026 → Aug 2026
| # | Stock | Sector | Weight (Aug 2026) |
|---|---|---|---|
| 1 | Cipla Limited ₹5.64 Cr |
Pharmaceuticals & Biotechnology | 1.39% |
| 2 | Neogen Chemicals Limited ₹84.83 L |
Chemicals & Petrochemicals | 0.21% |
| # | Stock | Sector | Jul 2026 | Aug 2026 | Change |
|---|---|---|---|---|---|
| 1 | Zydus Lifesciences Limited ₹10.41 Cr |
Pharmaceuticals & Biotechnology | 1.33% | 2.56% | +1.23% |
| 2 | Divi's Laboratories Limited ₹42.82 Cr |
Pharmaceuticals & Biotechnology | 9.67% | 10.55% | +0.88% |
| 3 | Rubicon Research Limited ₹27.66 Cr |
Pharmaceuticals & Biotechnology | 6.01% | 6.81% | +0.80% |
| 4 | Piramal Pharma Limited ₹27.27 Cr |
Pharmaceuticals & Biotechnology | 6.60% | 6.72% | +0.12% |
| 5 | IPCA Laboratories Limited ₹9.97 Cr |
Pharmaceuticals & Biotechnology | 2.34% | 2.46% | +0.12% |
| 6 | Vijaya Diagnostic Centre Limited ₹9.37 Cr |
Healthcare Services | 2.20% | 2.31% | +0.11% |
| 7 | GlaxoSmithKline Pharmaceuticals Limited ₹7.26 Cr |
Pharmaceuticals & Biotechnology | 1.68% | 1.79% | +0.11% |
| 8 | Turtlemint Fintech Solutions Limited ₹3.74 Cr |
Financial Technology (Fintech) | 0.83% | 0.92% | +0.09% |
| 9 | Glenmark Pharmaceuticals Limited ₹6.88 Cr |
Pharmaceuticals & Biotechnology | 1.64% | 1.70% | +0.06% |
| 10 | Aurobindo Pharma Limited ₹25.09 Cr |
Pharmaceuticals & Biotechnology | 6.13% | 6.18% | +0.05% |
| # | Stock | Sector | Jul 2026 | Aug 2026 | Change |
|---|---|---|---|---|---|
| 1 | Navin Fluorine International Limited ₹4.00 Cr |
Chemicals & Petrochemicals | 2.01% | 0.99% | -1.02% |
| 2 | Sun Pharmaceutical Industries Limited ₹33.31 Cr |
Pharmaceuticals & Biotechnology | 8.87% | 8.21% | -0.66% |
| 3 | Emcure Pharmaceuticals Limited ₹15.59 Cr |
Pharmaceuticals & Biotechnology | 4.37% | 3.84% | -0.53% |
| 4 | Apollo Hospitals Enterprise Limited ₹24.34 Cr |
Healthcare Services | 6.50% | 6.00% | -0.50% |
| 5 | Torrent Pharmaceuticals Limited ₹20.43 Cr |
Pharmaceuticals & Biotechnology | 5.48% | 5.03% | -0.45% |
| 6 | Max Healthcare Institute Limited ₹13.59 Cr |
Healthcare Services | 3.80% | 3.35% | -0.45% |
| 7 | Zydus Wellness Limited ₹9.20 Cr |
Food Products | 2.66% | 2.27% | -0.39% |
| 8 | Fortis Healthcare Limited ₹10.90 Cr |
Healthcare Services | 3.01% | 2.69% | -0.32% |
| 9 | Neuland Laboratories Limited ₹16.66 Cr |
Pharmaceuticals & Biotechnology | 4.42% | 4.11% | -0.31% |
| 10 | SANOFI CONSUMER HEALTHCARE ₹5.74 Cr |
Pharmaceuticals & Biotechnology | 1.70% | 1.41% | -0.29% |
34 stocks — Aug 2026
| # | Stock | Sector | Cap | Weight & Value |
|---|---|---|---|---|
| 1 |
₹42.82 Cr |
Pharmaceuticals & Biotechnology |
10.55%
|
|
| 2 |
₹33.31 Cr |
Pharmaceuticals & Biotechnology |
8.21%
|
|
| 3 |
₹27.66 Cr |
Pharmaceuticals & Biotechnology |
6.81%
|
|
| 4 |
₹27.27 Cr |
Pharmaceuticals & Biotechnology |
6.72%
|
|
| 5 |
₹25.09 Cr |
Pharmaceuticals & Biotechnology |
6.18%
|
|
| 6 |
₹24.34 Cr |
Healthcare Services |
6.00%
|
|
| 7 |
₹20.43 Cr |
Pharmaceuticals & Biotechnology |
5.03%
|
|
| 8 |
₹16.66 Cr |
Pharmaceuticals & Biotechnology |
4.11%
|
|
| 9 |
₹15.59 Cr |
Pharmaceuticals & Biotechnology |
3.84%
|
|
| 10 |
₹13.59 Cr |
Healthcare Services |
3.35%
|
Disclaimer: Data sourced from individual AMC monthly portfolio disclosures, as mandated by SEBI/AMFI. While we strive for accuracy, errors in parsing or presentation may occasionally occur. This is not investment advice. Please consult a SEBI-registered investment adviser before making any investment decisions.
Found a discrepancy or have feedback? Contact Us — we read every message personally.